Rocket Lab charges more for Neutron before its first flight as launch capacity tightens

Rocket Lab (Nasdaq: RKLB) lifted the base launch price of its Neutron rocket to $70 million for several missions signed in the third quarter, before the rocket's first flight, the company said in its results release on Monday, November 9. Quarterly revenue reached a record $268 million.

Customers are booking a rocket that has not flown

Rocket Lab said it secured more than $515 million of Neutron launch contracts from constellation operators in the quarter ended September 30, taking the rocket's backlog to 16 missions ahead of its debut. The higher base price applies to several of those missions "as industry launch capacity tightens," the company said. It put Neutron's first launch at no earlier than 2027.

Across its rockets, Rocket Lab said it signed about $1 billion of new launch contracts in the quarter, for a total launch backlog of 117 launches. Founder and CEO Peter Beck said the company had also signed $470 million of Space Systems work, its business building spacecraft and components, and that the total backlog "has grown to $3.57 billion." The release put that at a 52% increase since the end of the second quarter.

Revenue rose faster than gross profit

Total revenue was $267.8 million, up 73% from $155.1 million a year earlier, according to the release. Product revenue, which includes spacecraft and components, rose to $197.5 million from $104.0 million, and service revenue to $70.3 million from $51.0 million.

Gross profit under US GAAP rose to $90.1 million from $57.3 million, but the gross margin, gross profit as a share of revenue, narrowed to 33.6% from 37.0%, by FinanceInTime's calculation. Research and development spending rose to $98.4 million from $70.7 million, and the operating loss widened to $79.2 million from $59.0 million.

The net loss was $79.7 million, against $18.3 million a year earlier. Two items outside operations moved that comparison: the third quarter of 2025 included a $41.1 million income tax benefit, and the latest quarter included a $27.3 million loss on extinguishment of debt. Interest income rose to $28.6 million from $6.7 million.

Equity sales paid for the next deal

Cash and cash equivalents stood at $4.45 billion on September 30, up from $828.7 million at the end of 2025, according to the balance sheet in the release. Financing activities brought in $3.86 billion in the first nine months of 2026, while operating activities used $127.3 million over the same period. In the third quarter alone, operating cash flow was positive at $7.2 million under GAAP, the company said.

Rocket Lab said it had fully funded its pending acquisition of Iridium Communications through a completed at-the-market (ATM) equity offering, in which a company sells new shares into the market over time, and that Iridium shareholders had approved the deal.

For the fourth quarter, the company guided to revenue of $270 million to $290 million, a GAAP gross margin of 34% to 36% and an adjusted EBITDA loss, a measure that excludes items such as interest, taxes and depreciation, of $14 million to $20 million.

Charging more before the first launch is the test of this backlog

We think the price increase says more about Rocket Lab's position than the record revenue does. A company that can raise the price of an unflown rocket while booking 16 Neutron missions is showing pricing power, and that fits our view that strategy shows first in what customers will pay. The opportunity is that higher-priced Neutron launches lift margins once the rocket flies; the guidance of 34% to 36% suggests the company expects some recovery from 33.6%.

The threat is timing. Much of the backlog depends on a rocket whose debut is set for 2027 at the earliest, while research spending and an acquisition funded with new shares draw on the cash pile. We would weigh the fourth-quarter gross margin and any change to Neutron's launch date before the backlog figure, and we would revise this view if customers renegotiate prices or the first flight slips beyond 2027.

The view in this final section is FinanceInTime's editorial opinion, for information only. It is not investment, tax, legal or other advice, and it does not take your circumstances into account. Forecasts are uncertain and past results do not guarantee future ones.